Dale, after undergoing emergent coronary artery bypass graft surgery, is preparing for discharge. His total cholesterol is 260 mg/dL, and his LDL is 220 mg/dL. He was started on simvastatin 40 mg daily. After the lipid panel was completed, simvastatin was prescribed. Dale was also started on 81 mg of aspirin daily. Answer the following questions: When would the provider anticipate seeing results from simvastatin? Provide an analysis of potential drug and food interactions with simvastatin. What laboratory tests should be monitored? What teaching should be provided to Dale about simvastatin, and what are the rationales? What are non-pharmacological strategies should be implemented to reduce cholesterol? Explain why Dale started on aspirin.
[Expert Solution]: Dale, after undergoing emergent coronary…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.